Literature DB >> 21358455

Roles of epithelial-mesenchymal transition in squamous cell carcinoma of the temporal bone.

Hisashi Sugimoto1, Makoto Ito, Miyako Hatano, Satoru Kondo, Shioto Suzuki, Tomokazu Yoshizaki.   

Abstract

OBJECTIVES: The authors recently demonstrated that extensive bone erosion correlated with a worse prognosis of the squamous cell carcinoma (SCC) of the temporal bone. The present objective was to investigate the expressions and the roles of epithelial-mesenchymal transition (EMT) in SCC of the temporal bone. STUDY
DESIGN: Retrospective patient file review and immunohistochemical study of tissues of patients with SCC of the temporal bone. PATIENTS: The authors examined the expressions of vimentin in 16 patients with SCC of the temporal bone by immunohistochemical analysis.
RESULTS: As expected, vimentin was expressed on SCC of the temporal bone. We regard the patient who has vimentin-positive cells as EMT-positive patient because gain of vimentin is a hallmark in the EMT reported in several types of cancer. EMT positive tumors significantly correlated with extensive bone erosion, and extensive bone erosion correlated with a worse prognosis of the SCC of the temporal bone.
CONCLUSION: The study results suggest that EMT in tumor cells becomes an important indicator of poor prognosis in SCC of the temporal bone.
© 2011, Otology & Neurotology, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358455     DOI: 10.1097/MAO.0b013e31820d9654

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma.

Authors:  Go Omura; Mizuo Ando; Yuki Saito; Osamu Fukuoka; Ken Akashi; Masafumi Yoshida; Akinobu Kakigi; Takahiro Asakage; Tatsuya Yamasoba
Journal:  Int J Clin Oncol       Date:  2017-01-02       Impact factor: 3.402

Review 2.  Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.

Authors:  Gino Marioni; Alessandro Martini; Niccolò Favaretto; Sebastiano Franchella; Rocco Cappellesso; Filippo Marino; Stella Blandamura; Antonio Mazzoni; Elisabetta Zanoletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-30       Impact factor: 2.503

3.  Relaxin-2 expression in temporal bone carcinoma.

Authors:  Gino Marioni; Elisabetta Zanoletti; Andrea Lovato; Sebastiano Franchella; Luciano Giacomelli; Andrea Gianatti; Antonio Mazzoni; Stella Blandamura; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-12       Impact factor: 2.503

4.  Temporal Bone Squamous Cell Carcinoma: Molecular Markers Involved in Carcinogenesis, Behavior, and Prognosis: A Systematic Review.

Authors:  Lara Alessandrini; Laura Astolfi; Leonardo Franz; Erica Gentilin; Antonio Mazzoni; Elisabetta Zanoletti; Gino Marioni
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

5.  Temporal bone carcinoma: Classical prognostic variables revisited and modern clinico-pathological evidence.

Authors:  Elisabetta Zanoletti; Gino Marioni; Sebastiano Franchella; Sara Munari; Roberto Pareschi; Antonio Mazzoni; Alessandro Martini
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

6.  Let-7c inhibits migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2.

Authors:  Bo Hou; Hajime Ishinaga; Kaoru Midorikawa; Satoshi Nakamura; Yusuke Hiraku; Shinji Oikawa; Ning Ma; Kazuhiko Takeuchi; Mariko Murata
Journal:  Oncotarget       Date:  2018-01-02

Review 7.  Squamous cell carcinoma of the temporal bone: A current review.

Authors:  Benjamin D Lovin; Paul W Gidley
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.